Filters

Betaxolol manufacturers

Filters

None products found

betaxolol

Eye drops 5.6 mg/ml - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Portugal
Manufacturer #1858

This company, with a global presence, has been operating for over nine decades, demonstrating its experience and commitment to the healthcare industry. They provide a diverse portfolio of products, including prescription medications, healthcare solutions, and animal nutrition products. Their focus is on areas like allergies, gastrointestinal health, and immune system support. Key dosage forms include solids, liquids, and orals. They have manufacturing facilities in the EU and hold EU GMP approvals. They actively engage in research and development, investing in new molecules and clinical trials. Their commitment to sustainability is reflected in their focus on reducing environmental impact and promoting social responsibility. They operate in key regions including Europe, North America, and Latin America. While specific countries are not mentioned, the company emphasizes its international reach through a global network of partners.

Manufacturer usually replies in 12 days

betaxolol

Tablets 10 mg, 20 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18865
This company is a leading developer, manufacturer, and marketer of FDA-approved generic pharmaceuticals in the United States. They specialize in producing prescription medications, with a particular focus on weight management solutions like phentermine hydrochloride (Lomaira). Their commitment to quality is evident in their adherence to stringent FDA, DEA, and DEP guidelines. They manufacture all products domestically within state-of-the-art facilities. While they primarily operate in North America, recent partnerships suggest expansion into global markets. Their product portfolio features a variety of dosage forms and addresses several key therapy areas, including obesity management. The company holds patents on certain products and emphasizes affordability as a core value proposition.

Manufacturer usually replies in 6 days

betaxolol

Eye drops 0.5 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #17331
This company has been operating in the pharmaceutical industry for over five decades, demonstrating a strong commitment to healthcare solutions. They specialize in manufacturing finished dosage formulations, biosimilars, and API/DC granules, catering to diverse needs within the healthcare market. Their focus on research and development drives innovation and ensures high-quality products, while their commitment to regulatory compliance ensures patient safety and efficacy. They possess extensive experience in the pharmaceutical industry, with a global reach and a strong presence in key regions like Asia and North America. Their production lines are compliant with EU and US GMP standards, reflecting their dedication to quality and adherence to international best practices. Key therapy areas include oncology, cardiology, and other areas where biosimilars are widely used. They offer a variety of dosage forms including solids, liquids, and injectables. While specific product patents are not explicitly mentioned, their focus on innovation and research suggests they actively pursue intellectual property protection for their offerings.

Manufacturer usually replies in 2 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.